FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 33 filers reported holding FORTE BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156 | +8.3% | 235 | +70.3% | 0.00% | – |
| Q2 2023 | $144 | +8.3% | 138 | +4.5% | 0.00% | – |
| Q1 2023 | $133 | +5.6% | 132 | +4.8% | 0.00% | – |
| Q4 2022 | $126 | – | 126 | +41.6% | 0.00% | – |
| Q3 2022 | $0 | – | 89 | +15.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 77 | -99.8% | 0.00% | – |
| Q1 2022 | $62,000 | +287.5% | 42,584 | +486.1% | 0.00% | – |
| Q4 2021 | $16,000 | -55.6% | 7,266 | -41.8% | 0.00% | – |
| Q3 2021 | $36,000 | -94.2% | 12,486 | -32.1% | 0.00% | – |
| Q2 2021 | $619,000 | +30850.0% | 18,386 | +27757.6% | 0.00% | – |
| Q1 2021 | $2,000 | -99.1% | 66 | -99.0% | 0.00% | – |
| Q4 2020 | $230,000 | +7566.7% | 6,316 | +11596.3% | 0.00% | – |
| Q3 2020 | $3,000 | – | 54 | +58.8% | 0.00% | – |
| Q2 2020 | $0 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 66,390 | $2,232,000 | 1.54% |
| BVF INC/IL | 591,811 | $19,897,000 | 0.75% |
| Endurant Capital Management LP | 53,369 | $1,794,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,183,213 | $39,780,000 | 0.30% |
| Perceptive Advisors | 1,370,000 | $46,060,000 | 0.30% |
| ACT CAPITAL MANAGEMENT, LLC | 16,071 | $541,000 | 0.28% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 516,956 | $17,380,000 | 0.26% |
| Parkman Healthcare Partners LLC | 31,402 | $1,056,000 | 0.23% |
| Insight Advisors, LLC/ PA | 19,150 | $582,000 | 0.18% |
| MYDA Advisors LLC | 20,000 | $672,000 | 0.17% |